In a report released yesterday, Tycho Peterson from J.P. Morgan reiterated a Hold rating on Foundation Medicine (NASDAQ: FMI), with
Category: Healthcare
Analysts’ Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alnylam Pharma
Analysts Are Bullish on These Healthcare Stocks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on K2M Group
The CFO of ImmunoGen (NASDAQ: IMGN) is Buying Shares
Today, the CFO of ImmunoGen (NASDAQ: IMGN), David Brannon Johnston, bought shares of IMGN for $16.9K. This recent transaction increases
Benchmark Co. Reiterates a Buy Rating on BioTelemetry
In a report released today, Jan Wald from Benchmark Co. reiterated a Buy rating on BioTelemetry (NASDAQ: BEAT), with a
Neurocrine Received its Third Buy in a Row
After Piper Jaffray and BMO Capital assigned a Buy rating to Neurocrine in the last month, the company received another
Alkermes Receives a Buy from Leerink Swann
Leerink Swann analyst Paul Matteis reiterated a Buy rating on Alkermes (NASDAQ: ALKS) yesterday and set a price target of